Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Renal Replacement Therapy is Scopus-indexed (Q3, CiteScore 1.5), WoS ESCI, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2059-1381Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Transplantation | 35 / 55 | 37th | Q3 |
| Nephrology | 57 / 88 | 35th | Q3 |
| Urology | 81 / 123 | 34th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q3, CiteScore 1.5.
Renal Replacement Therapy is Q3 in Transplantation (rank 35 of 55), Q3 in Nephrology (rank 57 of 88) and Q3 in Urology (rank 81 of 123), by CiteScore 2025.
Renal Replacement Therapy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.5, which places it in quartile Q3 at the 37th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.358, quartile Q3, with an H-index of 25.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Renal Replacement Therapy is published by BioMed Central Ltd. Its ISSN is 2059-1381.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Renal Replacement Therapy has an h-index of 31 and a 2-year mean of 1.47 citations per paper (OpenAlex). Its Scopus CiteScore is 1.5, quartile Q3. On 2-year citations it ranks #20 of 53 Scopus journals in Transplantation.
Renal Replacement Therapy published 102 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from Japan (80%), China (3.7%) and Italy (2.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.